Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid Diagnostic Test Reliable for Pregnancy-Associated Malaria

By LabMedica International staff writers
Posted on 10 Jul 2012
Microscopy is the gold standard in malaria diagnosis, but it has limited detection and availability, so rapid diagnostic tests (RDTs) could be an ideal diagnostic complement to microscopy. More...


When used appropriately, RDTs are easy to use and have adequate sensitivity in detecting even submicroscopic infections and the accuracy and reliability these tests has been evaluated in diagnosing pregnancy-associated malaria (PAM) compared to microscopy and PCR.

Scientists at the National Institute for Medical Research (Tanga, Tanzania) collaborating with an international team, followed a cohort of women throughout pregnancy for detection of plasmodial infection using venous and placental blood samples. They evaluated the malaria status by histidine rich protein 2 (HRP-2) and parasite lactate dehydrogenase (pLDH) based RDTs or HRP-2 only, microscopy and nested Plasmodium species diagnostic polymerase chain reaction (PCR).

From a cohort of 924 pregnant women who completed the follow up, complete RDT and microscopy data was available for 5,555 blood samples and of these 442 samples were analysed by PCR. Parascreen (Zephyr Biomedicals; Goa, India) is an RDT that detects HRP-2 antigen from Plasmodium falciparum and pLDH from the Plasmodium species and was used for the majority of samples in this study. A minority of samples were tested by Paracheck Pf (Orchid Biomedical Systems; Mumbai, India) or ParaHITf (Span diagnostics Ltd.; Surat, India), the commonly available RDTs in the study area.

Of the 5,555 blood samples, 49 samples were positive by microscopy and 91 by RDT. Forty-six of the RDT positive samples were positive and negative by microscopy, respectively, whereas nineteen of the microscopy negative, but RDT positive, samples were positive by PCR. Three samples were positive by microscopy, but negative by RDT and 351 of the 5,461 samples negative by both RDT and microscopy were tested by PCR and found negative. There was no statistically significant difference between the performances of the different RDTs.

The authors concluded that microscopy underestimated the real burden of malaria during pregnancy and RDTs performed better than microscopy in diagnosing PAM. In areas where intermittent preventive treatment during pregnancy may be abandoned due to low and decreasing malaria risk and instead replaced with active case management, screening with RDT is likely to identify most infections in pregnant women and out-performs microscopy as a diagnostic tool. The study was published on June 21, 2012, in the Malaria Journal.

Related Links:
National Institute for Medical Research
Zephyr Biomedicals
Orchid Biomedical Systems


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.